Tag: TLD HIV regimen
Antiretroviral Generics in Africa: How Local Production Is Transforming HIV Treatment Access
African-made antiretroviral generics are transforming HIV treatment access, with the first WHO-prequalified TLD regimen produced in Kenya and delivered to Mozambique in 2025. Local production is reducing dependency on imports, cutting costs, and building long-term health sovereignty.
Nov 24 2025
